This content is machine translated Hematology Challenges and opportunities of precision therapy In recent years, the ever-improving molecular understanding of malignant diseases has opened up avenues for targeted treatment strategies. Tumor genomic analyses are becoming increasingly important in providing patients with access…
View Post 2 min This content is machine translated Multiple Myeloma Focus on symptom control – treatment options at a glance One of the most important decisions that must be made at the onset of symptomatic myeloma is that of adequate therapy. While not yet curable, a number of good options…
View Post 5 min This content is machine translated Comorbid iron deficiency in heart failure Evidence-based beneficial effects of intravenous iron supplementation. Iron deficiency is common in heart failure patients. In addition to a reduction in exercise capacity and quality of life, an increased risk of mortality is associated with it –…
View Post 3 min This content is machine translated Pediatric Oncology No cancer like any other: when life stops Cancer in childhood and adolescence places special demands on both those affected and the physicians treating them. Specialized, interdisciplinary centers therefore work closely in defined infrastructures to ensure the survival…
View Post 3 min This content is machine translated Polycythaemia vera Effective therapy management with regard to the risk of thrombosis Hyperproliferation of the three cell series in the bone marrow causes erythrocytosis, thrombocytosis, and leukocytosis in polycythaemia vera. The result is, among other things, a significant increase in hematocrit levels…
View Post 3 min This content is machine translated Case report: Pregnancy and birth Von Willebrand syndrome with impressive bleeding history A patient who had already suffered four miscarriages related to bleeding complications presents for thrombophilia screening at the 6th week of gestation. During the diagnostic process, Von Willebrand syndrome is…
View Post 3 min This content is machine translated Hematologic malignancies Lymphocytic lymphomas and leukemias: focus on current therapies Malignant hematologic diseases such as leukemias or lymphomas represent the fourth most common cancer and affect approximately 20/100,000 population per year in Europe. A number of effective substances are now…
View Post 2 min This content is machine translated Immunotherapy Keeping an eye on iron status during tumor therapy Iron deficiency is not only common in malignancies, but also a risk factor for impaired efficacy of antitumor treatment. Accordingly, transferrin saturation should be kept in view and iron supplementation…
View Post 2 min This content is machine translated Case report: Pregnancy Von Willebrand syndrome and anti-phospholipid syndrome A patient with anti-phospholipid syndrome undergoes fertility treatment because she had already suffered two miscarriages. During a laboratory examination at the beginning of pregnancy, Von Willebrand syndrome is also diagnosed.…
View Post 3 min This content is machine translated Immunotherapy Wider use for CAR-T cell treatment possible in the future? CAR-T cells have solved a central problem in cancer therapy – they make tumors visible again to the immune system. The initial successes in B-cell lymphomas are now attracting a…
View Post 4 min This content is machine translated Hematologic neoplasms Highlights and current data from the world of hematology ASH attendees immersed themselves in the world of hematology at the end of 2019. They learned about current trial data and findings around multiple myeloma, CAR-T cell therapy in LBCL,…
